# MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)

> **NCT07635108** · NA · NOT_YET_RECRUITING · sponsor: **Odense University Hospital** · enrollment: 48 (estimated)

## Conditions studied

- Prostate Cancer
- Oligo-metastatic Prostate Carcinoma
- Oligometastatic Cancer
- Nodal Oligorecurrent Prostate Cancer

## Interventions

- **RADIATION:** Single-fraction SBRT

## Key facts

- **NCT ID:** NCT07635108
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2030-04
- **Final completion:** 2035-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635108, "MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*